Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Fresenius Kabi Ltd.

Fresenius Kabi is the leading European provider of clinical nutrition and infusion therapy offering a unique and comprehensive range of products and services for both hospital and home settings. From our expertise in nutrition and infusion therapies, and through dedication to people through innovation we are committed to becoming the preferred partner worldwide for saving, treatment and caring for chronically ill patients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Fresenius Kabi Ltd.
Cestrian Court, Eastgate Way, Runcorn, Cheshire, WA7 1NT
+44 (0) 1928-533 533
Contact Fresenius Kabi Ltd.
Website

 Latest Content from PMHub 

Report: Living with RA (EU, Japan and Canada) 2019 reports

White Papers and Resources | March 1, 2019 | Inizio

Research Partnership launches new patient Living with  Rheumatoid Arthritis (EU & Japan)  2019 report.r Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in...

News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

White Papers and Resources | March 1, 2019 | Inizio

A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter. In addition from Q1...

Emerging Markets: Your Essential Guide

White Papers and Resources | March 1, 2019 | Inizio

Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges...

Live webinar: Navigating new frontiers: Ways to find space in the future RA market

White Papers and Resources | March 1, 2019 | Inizio

In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...

Bluedog Launch Celebrations

Videos and Podcasts | February 28, 2019 | Lucid Group Communications Limited

Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary.  2019 is set to be a...

Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis

Press Releases | February 28, 2019 | Porterhouse Medical Group

An interview with Debbie, office manager at Porterhouse Medical, on what it’s like to live with the rare disease, PSC. Read more ...

Rare Disease Day 2019

White Papers and Resources | February 28, 2019 | Cuttsy + Cuttsy

Today is #RareDiseaseDay and is an opportunity to highlight some truly unbelievable/frightening statistics around rare diseases.

Health Literacy in Practice: Doctor’s Letter

White Papers and Resources | February 25, 2019 | Cuttsy + Cuttsy

If a patient was given their results directly, how could we make it into something they could understand and, most importantly, act on?

Are you capitalising on your pharma exhibition presence?

Press Releases | February 25, 2019 | Apex Events and Exhibitions

When it comes to exhibition success, pharma companies have lots of things to consider. This includes making sure that you have quality pharma exhibition stands that sparks conversations. But, to...

How Medisafe is using AI to improve patient adherence

White Papers and Resources | February 20, 2019 | Blue Latitude Health

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.